Nonalcoholic Fatty Liver Disease (Japanese Version)
Authors: Xiao Jing Wang, Harmeet Malhi
Journal: Annals of Internal Medicine (2018)

In the Clinic6 November 2018Nonalcoholic Fatty Liver Disease (Japanese Version)FREEXiao Jing Wang, MD and Harmeet Malhi, MDXiao Jing Wang, MDFrom the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. (X.J.W., H.M.) and Harmeet Malhi, MDFrom the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. (X.J.W., H.M.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/IsTranslatedFrom_AITC201811060_Japanese SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Editors' Note: This article (available in PDF format) is the translated Japanese version of In the Clinic: Nonalcoholic Fatty Liver Disease (Wang XJ, Malhi H. Nonalcoholic Fatty Liver Disease. Ann Intern Med. 2018;169:ITC65-ITC80. doi:10.7326/AITC201811060. Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAffiliations: From the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. (X.J.W., H.M.)CME Objective: To review current evidence for diagnosis, treatment, and practice improvement of nonalcoholic fatty liver disease.Funding Source: American College of Physicians.Disclosures: Dr. Wang, ACP Contributing Author, has nothing to disclose. Dr. Malhi, ACP Contributing Author, reports grants from the National Institute of Diabetes and Digestive and Kidney Diseases, Gilead Sciences, the Palumbo Foundation, and the Mayo Foundation during the conduct of the study and other support from Pfizer, Conatus, Intercept, and Gilead outside the submitted work. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-1338.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Proctor & Gamble, Pfizer, and Johnson & Johnson.With the assistance of additional physician writers, the editors of Annals of Internal Medicine develop In the Clinic using MKSAP and other resources of the American College of Physicians.In the Clinic does not necessarily represent official ACP clinical policy. For ACP clinical guidelines, please go to https://www.acponline.org/clinical_information/guidelines/. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoNonalcoholic Fatty Liver Disease Xiao Jing Wang and Harmeet Malhi Metrics Cited byEfficacy and mechanism of intermittent fasting in metabolic associated fatty liver disease based on ultraperformance liquid chromatography-tandem mass spectrometry 6 November 2018Volume 169, Issue 9Page: JITC65-JITC80 ePublished: 20 September 2022 Issue Published: 6 November 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...